ARMISTICE CAPITAL, LLC
Position in CRL — Charles River Laboratories International, Inc.
CIK 1601086
NEW YORK, NY
Position in CRL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$204,111
-$98,169 QoQ
Shares Held
900
-53.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#403
of 564 holders
Holding Since
Sep 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ARMISTICE CAPITAL, LLC holds $125,866,829 across 7 Diagnostics & Research names. CRL ranks #7 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
122,480 | $61,406,572 | |
| 2 | WAT |
Waters Corp /De/
|
75,004 | $28,129,500 | |
| 3 | ILMN |
Illumina, Inc.
|
91,118 | $16,021,277 | |
| 4 | TWST |
Twist Bioscience Corp
|
142,000 | $14,608,960 | |
| 5 | DHR |
Danaher Corp /De/
|
20,500 | $3,904,840 | |
| 6 | A |
Agilent Technologies, Inc.
|
11,982 | $1,591,569 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
This page
|
900 | $204,111 |
All Filings in CRL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $204,111 | 900 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $302,280 | 1,932 | Shares | Sole | 2025-11-17 | |
| 2024-06-30 | $24,597,687 | 119,071 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $18,934,527 | 69,882 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,510,400 | 36,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $30,572,880 | 156,000 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||